News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
253,187 Results
Type
Article (16545)
Company Profile (27)
Press Release (236615)
Multimedia
Podcasts (37)
Webinars (5)
Section
Business (64494)
Career Advice (645)
Deals (10622)
Drug Delivery (41)
Drug Development (41551)
Employer Resources (36)
FDA (6988)
Job Trends (5579)
News (123400)
Policy (12075)
Tag
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
Academia (1500)
Accelerated approval (15)
Adcomms (13)
Allergies (49)
Alliances (14487)
ALS (101)
Alzheimer's disease (1120)
Antibody-drug conjugate (ADC) (118)
Approvals (7167)
Artificial intelligence (158)
Autoimmune disease (59)
Automation (16)
Bankruptcy (119)
Best Places to Work (5006)
BIOSECURE Act (2)
Biosimilars (46)
Biotechnology (18)
Bladder cancer (118)
Brain cancer (23)
Breast cancer (280)
Cancer (2263)
Cardiovascular disease (237)
Career advice (537)
Career pathing (14)
CAR-T (114)
CDC (20)
Cell therapy (311)
Cervical cancer (13)
Clinical research (35595)
Collaboration (556)
Company closure (1)
Compensation (352)
Complete response letters (30)
COVID-19 (1071)
CRISPR (42)
C-suite (233)
Cystic fibrosis (78)
Data (3755)
Denatured (2)
Depression (64)
Diabetes (281)
Diagnostics (2488)
Digital health (12)
Diversity (1)
Diversity, equity & inclusion (13)
Drug discovery (86)
Drug pricing (48)
Drug shortages (16)
Duchenne muscular dystrophy (240)
Earnings (31599)
Editorial (18)
Employer branding (3)
Employer resources (33)
Events (38119)
Executive appointments (292)
FDA (8631)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (7)
Frontotemporal dementia (18)
Funding (488)
Gene editing (95)
Generative AI (15)
Gene therapy (428)
GLP-1 (484)
Government (2073)
Grass and pollen (1)
Guidances (260)
Healthcare (7936)
HIV (26)
Huntington's disease (21)
IgA nephropathy (61)
Immunology and inflammation (81)
Immuno-oncology (15)
Indications (53)
Infectious disease (1187)
Inflammatory bowel disease (74)
Inflation Reduction Act (4)
Influenza (36)
Intellectual property (110)
Interviews (88)
IPO (5685)
IRA (14)
Job creations (768)
Job search strategy (483)
JPM (22)
Kidney cancer (9)
Labor market (16)
Layoffs (158)
Leadership (9)
Legal (2007)
Liver cancer (40)
Longevity (5)
Lung cancer (304)
Lymphoma (232)
Machine learning (12)
Management (12)
Manufacturing (213)
MASH (169)
Medical device (4877)
Medtech (4902)
Mergers & acquisitions (5307)
Metabolic disorders (741)
Multiple sclerosis (85)
NASH (19)
Neurodegenerative disease (178)
Neuropsychiatric disorders (37)
Neuroscience (1792)
Neurotech (1)
NextGen: Class of 2026 (2345)
Non-profit (2011)
Now hiring (50)
Obesity (297)
Opinion (93)
Ovarian cancer (66)
Pain (121)
Pancreatic cancer (99)
Parkinson's disease (151)
Partnered (10)
Patents (171)
Patient recruitment (230)
Peanut (20)
People (18389)
Pharmaceutical (7)
Pharmacy benefit managers (7)
Phase 1 (10477)
Phase 2 (15990)
Phase 3 (12109)
Pipeline (2739)
Policy (98)
Postmarket research (1420)
Preclinical (4982)
Press Release (18)
Prostate cancer (103)
Psychedelics (16)
Radiopharmaceuticals (119)
Rare diseases (475)
Real estate (1068)
Recruiting (14)
Regulatory (10070)
Reports (9)
Research institute (1078)
Resumes & cover letters (105)
Rett syndrome (23)
RNA editing (9)
RSV (38)
Schizophrenia (94)
Series A (60)
Series B (50)
Service/supplier (1)
Sickle cell disease (54)
Special edition (3)
Spinal muscular atrophy (178)
Sponsored (11)
Startups (1076)
Stomach cancer (3)
Supply chain (31)
Tariffs (11)
The Weekly (34)
Vaccines (365)
Venture capital (19)
Weight loss (167)
Women's health (30)
Worklife (3)
Date
Last 7 days (228)
Last 30 days (763)
Last 365 days (13101)
2026 (1073)
2025 (13304)
2024 (15329)
2023 (17167)
2022 (20651)
2021 (22250)
2020 (20997)
2019 (17640)
2018 (13290)
2017 (12434)
2016 (11449)
2015 (13839)
2014 (9521)
2013 (7262)
2012 (7902)
2011 (8129)
2010 (7253)
Location
Africa (229)
Alabama (17)
Alaska (1)
Arizona (67)
Arkansas (4)
Asia (12283)
Australia (2558)
California (4945)
Canada (1300)
China (436)
Colorado (194)
Connecticut (176)
Delaware (149)
Europe (32161)
Florida (663)
Georgia (185)
Hawaii (1)
Idaho (19)
Illinois (356)
India (32)
Indiana (231)
Iowa (7)
Japan (219)
Kansas (68)
Kentucky (13)
Louisiana (18)
Maine (34)
Maryland (541)
Massachusetts (3347)
Michigan (108)
Minnesota (188)
Mississippi (2)
Missouri (43)
Montana (12)
Nebraska (12)
Nevada (49)
New Hampshire (34)
New Jersey (1532)
New Mexico (5)
New York (1442)
North Carolina (604)
North Dakota (5)
Northern California (2476)
Ohio (145)
Oklahoma (1)
Oregon (18)
Pennsylvania (951)
Puerto Rico (9)
Rhode Island (5)
South America (321)
South Carolina (18)
South Dakota (1)
Southern California (1986)
Tennessee (76)
Texas (712)
United States (17160)
Utah (154)
Virginia (94)
Washington D.C. (25)
Washington State (450)
West Virginia (1)
Wisconsin (26)
253,187 Results for "muscular dystrophy association".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Santhera Receives Swissmedic Approval of AGAMREE® (Vamorolone) for the Treatment of Duchenne Muscular Dystrophy
January 16, 2026
·
4 min read
Press Releases
Capricor Therapeutics and Parent Project Muscular Dystrophy to Host Webinar Highlighting Positive Phase 3 HOPE-3 Topline Results in Duchenne Muscular Dystrophy
December 17, 2025
·
4 min read
Press Releases
Atossa Therapeutics Receives FDA Orphan Drug Designation for (Z)-Endoxifen for the Treatment of Duchenne Muscular Dystrophy
January 19, 2026
·
5 min read
Press Releases
Atossa Therapeutics Maintains Strong Market Position for (Z)-Endoxifen for Duchenne Muscular Dystrophy as Congress Reauthorizes Priority Review Voucher Program
February 5, 2026
·
6 min read
Neurodegenerative disease
Avidity’s siRNA Muscular Dystrophy Drug Improves Mobility, Boosts Muscle Strength
Avidity has been given the go-ahead by the FDA to request accelerated approval of delpacibart braxlosiran—potentially the first disease-modifying treatment for facioscapulohumeral muscular dystrophy—with an application in the second half of 2026.
June 9, 2025
·
2 min read
·
Dan Samorodnitsky
Neurodegenerative disease
Edgewise Takes a Hit as FDA Blocks Accelerated Path for Becker Muscular Dystrophy Drug
The FDA found that data from a single Phase II study were “insufficient” to justify an accelerated approval review for sevasemten in Becker muscular dystrophy.
June 27, 2025
·
2 min read
·
Tristan Manalac
Press Releases
UPSHER-SMITH LAUNCHES KYMBEE™ (DEFLAZACORT) TABLETS FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
December 2, 2025
·
6 min read
Press Releases
Sarepta Therapeutics to Report 3-Year Topline Data from EMBARK Study of ELEVIDYS Gene Therapy in Ambulatory Individuals with Duchenne Muscular Dystrophy
January 26, 2026
·
1 min read
Press Releases
Nxera Pharma Licenses Japan and Select Asia-Pacific Rights to Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals
January 8, 2026
·
9 min read
Press Releases
Ractigen Therapeutics Doses First Patient in IIT Study of RAG-18 for Duchenne Muscular Dystrophy
December 15, 2025
·
4 min read
1 of 25,319
Next
